Skip to main content
. Author manuscript; available in PMC: 2016 Aug 28.
Published in final edited form as: CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):463–468. doi: 10.2174/187152712800792884

Fig. 2.

Fig. 2

Chemical structures of ligands: (a) the novel potential inhibitor [4-(propan-2-yl) phenyl]carbamic acid, (b) L-tyrosine, (c) L-DOPA, (d) norepinephrine and (e) epinephrine. Each was docked with receptor tyrosine hydroxylase “2XSN”.